Insuman Comb 50 Solostar (Insulin Human)

Insuman Comb 50 Solostar is an insulin preparation used in the management of diabetes mellitus.

• Type 1 diabetes mellitus: provides basal and prandial insulin to maintain target blood glucose levels.
• Type 2 diabetes mellitus: used when oral agents are insufficient to achieve glycemic control, offering both basal and mealtime insulin coverage.

• Insulin Human binds to insulin receptors on muscle, adipose and hepatic cells, activating the receptor’s tyrosine kinase activity. This triggers intracellular signaling pathways that increase glucose transporter translocation, enhance glucose uptake, promote glycogen synthesis, and suppress hepatic gluconeogenesis, thereby lowering circulating blood glucose levels.

Insuman Comb 50 Solostar may cause a range of adverse reactions.

Common Side Effects

• Hypoglycemia: symptoms of low blood sugar such as shakiness, sweating, and confusion.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Weight gain: increase in body weight due to improved glucose utilization.
• Lipodystrophy: localized changes in fat tissue at injection sites.
• Edema: mild swelling of extremities.
• Nausea: occasional feeling of stomach upset.

Serious or Rare Side Effects

• Severe hypoglycemia: profound low blood sugar requiring assistance.
• Anaphylactic reaction: rare but potentially life‑threatening allergic response.
• Insulin antibodies: formation of antibodies that may alter insulin action.
• Severe edema: marked fluid retention possibly leading to heart failure.
• Hypokalemia: low potassium levels, especially with high insulin doses.
• Acute pancreatitis: rare inflammation of the pancreas.

When using Insuman Comb 50 Solostar, several safety considerations are recommended.

• Blood glucose monitoring: regularly check glucose levels to adjust dose as needed.
• Dose adjustment during illness: modify insulin dose if fever, infection, or stress alters glucose control.
• Renal or hepatic impairment: use caution and consider lower starting doses.
• Avoid use during hypoglycemia: do not administer additional insulin if blood sugar is already low.
• Patient education: teach signs of hypoglycemia and proper injection technique.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 50 Solostar can interact with other medicines, affecting its safety and efficacy.

Major Interactions (Avoid)

• Concurrent use of other insulin products: increases risk of severe hypoglycemia.
• Beta‑blockers: may mask hypoglycemia symptoms, making detection difficult.
• Glucocorticoids: can raise blood glucose, requiring higher insulin doses.

Moderate Interactions (Monitor Closely)

• Oral antidiabetic agents (e.g., sulfonylureas, meglitinides): additive glucose‑lowering effect.
• ACE inhibitors and ARBs: may enhance insulin sensitivity, necessitating dose review.
• Diuretics: can affect electrolyte balance and insulin action.